BioCentury
ARTICLE | Company News

CHMP backs Eylea for DME

June 27, 2014 11:50 PM UTC

EMA's CHMP backed approval of Eylea aflibercept from Bayer AG (Xetra:BAYN) to treat visual impairment due to diabetic macular edema. Eylea is approved in the U.S. and EU to treat wet age-related macul...